|
Safeguarding Female Fertility: The Necessity of Establishing a National Ovarian Biobank Network and Centralized Support Mechanisms
|
Tahere Mazoochi    , Elahe Haghparast * |
| , elahe.haghparast77@gmail.com |
|
|
Abstract: (29 Views) |
Executive Summary
Problem: Enhanced survival outcomes in cancer patients due to therapeutic progress, are often compromised by iatrogenic adverse effects like Premature Ovarian Failure (POF). In prepubertal or time-sensitive clinical scenarios, Ovarian Tissue Cryopreservation (OTC) remains the exclusive fertility preservation option [1]. However, the accessibility of OTC is currently impeded by various systemic barriers [2-4]
Implementation Considerations:
Legal & Ethical: Establishing clear regulations on tissue ownership, informed consent, and future usage.
Quality Standards: Adhering to international laboratory protocols and creating a national registry for outcome monitoring.
Equity: Expanding specialized centers within medical universities to ensure nationwide geographical and economic access.
Safety: Mitigating the risk of reintroducing malignant cells during transplantation.
Policy Options: Proposed interventions include: (1) Ratifying a national ethical-legal protocol, (2) Enhancing clinical evidence and public outreach, and (3) Incorporating fertility preservation services into the National Cancer Care Network to ensure systemic and timely referral pathways.
|
|
| Keywords: Ovarian Biobank, Fertility, Ovarian Tissue Cryopreservation |
|
|
|
Type of Study: Policy Brief |
Subject:
medicine, paraclinic
Received: 2025/12/21 | Revised: 2026/02/9 | Accepted: 2026/02/3
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
_-_Copy.png)
.png){kind=logo}
